Millions of Medicare beneficiaries face higher prescription drug costs and disappearing health plans as the 2027 open enrollment period forces seniors to navigate sweeping changes before the December 7 deadline. The Trump administration’s decision to end prescription drug subsidies threatens premium increases for half of all recipients, while insurance companies slash plan offerings across the country.
Prescription Drug Costs Set to Rise
The Centers for Medicare and Medicaid Services terminated the Part D Premium Stabilization Demonstration program earlier this year, eliminating subsidies that helped control prescription drug costs for tens of millions of older and disabled Americans. Dr. Mehmet Oz, who leads the agency, defended the decision by claiming the program primarily benefited insurance corporations rather than patients. The subsidies expire at year’s end, and administration officials confirmed roughly half of Medicare Part D recipients will see premium increases as a direct result.
The Medicare Payment Advisory Commission documented that these subsidies reduced average monthly prescription drug premiums by twenty-six dollars in 2025 and sixteen dollars in 2026. Timothy McBride, a health policy analyst at Washington University in St. Louis, warned the subsidy changes will create profound effects on beneficiaries. Oz countered on social media that most Medicare recipients would see premium increases no higher than ten dollars, claiming low-cost plans remain available for every beneficiary.
Insurance Plans Vanishing for Seniors
Approximately thirty-five million Americans enrolled in Medicare Advantage plans face a shrinking marketplace as private insurers reduce their offerings. Analysis from the Kaiser Family Foundation reveals the average Medicare beneficiary can now choose from thirty-five Medicare Advantage plans in 2027, down from thirty-nine plans in 2026. This contraction forces many seniors to find new coverage for the upcoming year as companies either scale back or completely eliminate their Medicare Advantage products.
The situation grows more critical for prescription drug coverage, with some counties losing access entirely. About one percent of Medicare Advantage beneficiaries will have zero prescription drug plans available during general enrollment, affecting residents in one hundred ninety-three counties, up from one hundred twenty-three counties in 2026. Health policy experts emphasize that beneficiaries must examine not just premiums but also deductibles and coverage caps when selecting replacement plans, as these factors significantly impact out-of-pocket costs throughout the year.
What Seniors Must Do Now
The federal health insurance program for those aged sixty-five and older offers enrollees until December 7 to choose between traditional Medicare and Medicare Advantage plans for 2027. Medicare Advantage plans are run by private insurance companies that must follow Medicare rules, including limits on out-of-pocket expenses and coverage of all services provided under traditional Medicare. With insurance companies retreating from the marketplace and prescription drug subsidies ending, seniors face a compressed timeline to evaluate their options and secure coverage before the enrollment window closes.